The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers

Women receiving neoadjuvant systemic therapy for primary operable or inoperable breast cancer can potentially benefit in a number of ways, but the main advantage, which has been consistently demonstrated, is improved tumour resectability. Given the improvement in outcomes with the adjuvant use of tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lemieux, J., Clemons, M., Provencher, L., Dent, S., Latreille, J., Mackey, J., Pritchard, K.I., Rayson, D., Verma, Sh., Verma, Su., Wang, B., Chia, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2009
Assuntos:
Practice Guidelines Series
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768514/
https://ncbi.nlm.nih.gov/pubmed/19862361
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados